Blood markers may warn of heart failure in diabetics

NCT ID NCT04941794

Recruiting now Knowledge-focused Sponsor: Regionshospital Nordjylland Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking for early warning signs in the blood that could predict chronic heart failure in people with type 2 diabetes. Researchers will follow 500 participants over time, using heart scans and blood tests to see if certain biomarkers can spot trouble before symptoms appear. The goal is to catch heart failure earlier, when it might be easier to manage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which people with type 2 diabetes are at risk for heart failure earlier, allowing for closer monitoring or earlier treatment.
What could go wrong: This is an observational study, not a treatment trial. It may not find reliable biomarkers, and any findings will need much more testing before they can be used in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HEART FAILURE TYPE 2 DIABETES

Contacts and locations

Locations

North Denmark Regional Hospital
RECRUITING

Hjørring, 9800, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.